Regulated Information - Global

Regulated Information

Filter

Period

Filter by

recent search

Showing: 105 of 152 Regulated Information

Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital

This article or press release has no online content. Please download the associated documents for more information.


Capital Markets Day 2020 – announcement
Capital Markets Day 2020 – announcement


Ipsen delivers sales growth in the first nine months of 2020 despite the impact of COVID-19 and confirms its 2020 full year guidance
Ipsen delivers sales growth in the first nine months of 2020 despite the impact of COVID-19 and confirms its 2020 full year guidance

Paris (France), 22 October 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter of 2020.



Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact

Paris (France), 22 April 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2020.


1 26 27 28 29 30 31